1
|
Ebrahimnejad P, Mohammadi Z, Babaei A, Ahmadi M, Amirkhanloo S, Asare-Addo K, Nokhodchid A. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications. Crit Rev Ther Drug Carrier Syst 2024; 41:35-84. [PMID: 37824418 DOI: 10.1615/critrevtherdrugcarriersyst.v41.i1.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2023]
Abstract
For more than a decade, researchers have been working to achieve new strategies and smart targeting drug delivery techniques and technologies to treat breast cancer (BC). Nanotechnology presents a hopeful strategy for targeted drug delivery into the building of new therapeutics using the properties of nanomaterials. Nanoparticles are of high regard in the field of diagnosis and the treatment of cancer. The use of these nanoparticles as an encouraging approach in the treatment of various cancers has drawn the interest of researchers in recent years. In order to achieve the maximum therapeutic effectiveness in the treatment of BC, combination therapy has also been adopted, leading to minimal side effects and thus an enhancement in the quality of life for patients. This review article compares, discusses and criticizes the approaches to treat BC using novel design strategies and smart targeting of site-specific drug delivery systems.
Collapse
Affiliation(s)
- Pedram Ebrahimnejad
- Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran; Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Zahra Mohammadi
- Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Amirhossein Babaei
- Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Melika Ahmadi
- Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Shervin Amirkhanloo
- Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Kofi Asare-Addo
- Department of Pharmacy, University of Huddersfield, Huddersfield, UK
| | - Ali Nokhodchid
- Lupin Pharmaceutical Research Center, Coral Springs, Florida, USA; Pharmaceutics Research Lab, Arundel Building, School of Life Sciences, University of Sussex, Brighton, UK
| |
Collapse
|
2
|
Qiu J, Chen L, Zhan M, Laurent R, Bignon J, Mignani S, Shi X, Caminade AM, Majoral JP. Facile Synthesis of Amphiphilic Fluorescent Phosphorus Dendron-Based Micelles as Antiproliferative Agents: First Investigations. Bioconjug Chem 2021; 32:339-349. [PMID: 33522223 DOI: 10.1021/acs.bioconjchem.0c00716] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We designed and synthesized several families of novel amphiphilic fluorescent phosphorus dendron-based micelles showing relevant antiproliferative activities for use in the field of theranostic nanomedicine. Based on straightforward synthesis pathways, 12 amphiphilic phosphorus dendrons bearing 10 protonated cyclic amino groups (generation one), or 20 protonated amino groups (generation two), and 1 hydrophobic chain carrying 1 fluorophore moiety were created. The amphiphilic dendron micelles had the capacity to aggregate in solution using hydrophilic/hydrophobic interactions, which promoted the formation of polymeric micelles. These dendron-based micelles showed moderate to high antiproliferative activities against a panel of tumor cell lines. This paper presents for the first time the synthesis and our first investigations of new phosphorus dendron-based micelles for cancer therapy applications.
Collapse
Affiliation(s)
- Jieru Qiu
- Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France.,College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China
| | - Liang Chen
- Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France.,College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China
| | - Mengsi Zhan
- College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China
| | - Régis Laurent
- Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France.,LCC-CNRS, Université de Toulouse, CNRS, 31077 Toulouse, France
| | - Jérôme Bignon
- Institut de Chimie des Substances Naturelles du CNRS, 1, avenue de la Terrasse, 91198 Paris, Gif-sur-Yvette Cedex, France
| | - Serge Mignani
- Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS UMR 860, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologique, 45, rue des Saints Peres, 75006, Paris, France.,CQM - Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal
| | - Xiangyang Shi
- College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China.,CQM - Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal
| | - Anne-Marie Caminade
- Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France.,LCC-CNRS, Université de Toulouse, CNRS, 31077 Toulouse, France
| | - Jean-Pierre Majoral
- Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France.,LCC-CNRS, Université de Toulouse, CNRS, 31077 Toulouse, France
| |
Collapse
|
3
|
Abdifetah O, Na-Bangchang K. Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review. Int J Nanomedicine 2019; 14:5659-5677. [PMID: 31632004 PMCID: PMC6781664 DOI: 10.2147/ijn.s213229] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Accepted: 05/31/2019] [Indexed: 01/19/2023] Open
Abstract
The poor pharmacokinetic characteristics of most anticancer drugs have limited their clinical effectiveness. The application of nanoparticles as a novel drug delivery system has provided opportunities to tackle the current challenges facing conventional drug delivery systems such as poor pharmacokinetics, lack of specificity to tumor cells, multidrug resistance, and toxicity. This systematic review aims to examine the application of pharmacokinetic studies of nanoparticles loaded in conventional drugs and herb-derived compounds for cancer therapy. The pharmacokinetic parameters of several herbal medicines and chemotherapeutic drugs loaded into nanoparticles were reported. This included area under the curve (AUC) of plasma concentration-time profile, maximum plasma concentration (Cmax), time to maximum plasma concentration (Tmax), volume of distribution (Vd or Vss), elimination half-life (t½), and clearance (CL). The systematic review was conducted using information available in the PubMed and Science Direct databases up to February 2019. The search terms employed were: pharmacokinetics, pharmacokinetic study, nanoparticles, anticancer, traditional medicine, herbal medicine, herb-derived compounds, natural products, and chemotherapy. Overall, nanoparticle carriers not only significantly improved pharmacokinetics but also further enhanced permeability, solubility, stability, specificity, and selectivity of the carried anticancer drugs/herb-derived compounds to target tumor cells. Additionally, they also limited hepatic first-pass metabolism and P-glycoprotein (P-gp) efflux of the carried anticancer drugs/herb-derived compounds. Based on this systematic review, polymeric nanoparticles were the most commonly used nanocarrier to improve the pharmacokinetic parameters. The use of nanoparticles as a novel drug delivery system has the potential to improve both pharmacokinetics and cytotoxicity activity of the loaded drugs/herb-derived compounds for cancer therapy.
Collapse
Affiliation(s)
- Omar Abdifetah
- Graduate Studies, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.,Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand
| | - Kesara Na-Bangchang
- Graduate Studies, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.,Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.,Drug Discovery Center, Thammasat University, Pathumthani, Thailand
| |
Collapse
|
4
|
|
5
|
Kosakowska KA, Casey BK, Kurtz SL, Lawson LB, Grayson SM. Evaluation of Amphiphilic Star/Linear–Dendritic Polymer Reverse Micelles for Transdermal Drug Delivery: Directing Carrier Properties by Tailoring Core versus Peripheral Branching. Biomacromolecules 2018; 19:3163-3176. [DOI: 10.1021/acs.biomac.8b00680] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Karolina A. Kosakowska
- Department of Chemistry, School of Science and Engineering, Tulane University, New Orleans Louisiana 70118, United States
- Bioinnovation PhD Program, School of Science and Engineering, Tulane University, New Orleans Louisiana 70118, United States
| | - Brittany K. Casey
- Department of Chemistry, School of Science and Engineering, Tulane University, New Orleans Louisiana 70118, United States
| | - Samantha L. Kurtz
- Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans Louisiana 70112, United States
- Bioinnovation PhD Program, School of Science and Engineering, Tulane University, New Orleans Louisiana 70118, United States
| | - Louise B. Lawson
- Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans Louisiana 70112, United States
| | - Scott M. Grayson
- Department of Chemistry, School of Science and Engineering, Tulane University, New Orleans Louisiana 70118, United States
| |
Collapse
|
6
|
Qiao H, Zhu Z, Fang D, Sun Y, Kang C, Di L, Zhang L, Gao Y. Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer. J Drug Target 2017; 26:75-85. [PMID: 28583001 DOI: 10.1080/1061186x.2017.1339195] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Multidrug resistance (MDR) severely hinders the efficient chemotherapeutic treatments of cancer. d-α-Tocopherol polyethylene 1000 succinate (TPGS) based drug delivery system holds the potential of re-sensitizing resistant cancer cells. In this study, a TPGS prodrug containing both TPGS and mitoxantrone (MTO) via a disulphide bond was synthesised and assembled into micelle (TSMm) with a monodispersed diameter of 46.50 ± 1.12 nm. The disulphide bonds within the micelles could be cleaved in response to a high concentration of intracellular glutathione (GSH) after entering the tumour cells, leading a rapid release of MTO. In vitro cytotoxicity study showed TSMm significantly inhibited the growth of resistant breast tumour cells MDA-MB-231/MDR comparing to either free MTO or disulphide-free prodrug micelle (TCMm). In addition, TSMm could sustain favourable intracellular retention and cause the depletion of ATP activity, leading to the preferential transportation of MTO into the nucleus and the reversal of MDR. In vivo imaging also verified that TSMm was specifically targeted to the tumour regions at 24 h post injection. Finally, TSMm has significantly stronger antitumor activity in xenograft nude mice with negligible side effects. Hence, TSMm can serve as promising prodrug candidates to strengthen the reversal of MDR in tumours with less side effects.
Collapse
Affiliation(s)
- Hongzhi Qiao
- a Jiangsu Engineering Research Centre for Efficient Delivery System of TCM, School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China
| | - Zhenzhu Zhu
- b State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science , Nanjing University , Nanjing , China
| | - Dong Fang
- a Jiangsu Engineering Research Centre for Efficient Delivery System of TCM, School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China
| | - Yuan Sun
- c Department of Chemistry and Biochemistry , The Ohio State University , Columbus , OH , USA
| | - Chen Kang
- d Department of Internal Medicine, Carver College of Medicine , University of Iowa , Iowa City , IA , USA
| | - Liuqing Di
- a Jiangsu Engineering Research Centre for Efficient Delivery System of TCM, School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China
| | - Lei Zhang
- a Jiangsu Engineering Research Centre for Efficient Delivery System of TCM, School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China
| | - Yahan Gao
- e State Key Laboratory of Natural Medicines, Department of Pharmaceutics , China Pharmaceutical University , Nanjing , China
| |
Collapse
|
7
|
Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy. Int J Biol Macromol 2016; 95:232-237. [PMID: 27864056 DOI: 10.1016/j.ijbiomac.2016.10.110] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2016] [Revised: 10/28/2016] [Accepted: 10/29/2016] [Indexed: 01/15/2023]
Abstract
Malignant melanoma is an aggressive form of skin cancer with high mortality rates. Common treatments for malignant melanoma involve a combination of radiotherapy and chemotherapy with fluorouracil (5-FU). A major challenge with melanoma treatment is active resistance to chemotherapeutic drugs. Superior treatment outcome lies on balance involving optimum therapeutic doses and the side effects associated with dose escalation. The study aimed to efficiently entrap 5-FU in lactoferrin nanoparticles (LfNPs) in an attempt to enhance its therapeutic efficacy. 5-FU loaded lactoferrin nanoparticles (5-FU-LfNPs) were prepared by sol-oil method with a narrow size distribution of 150±20nm 5-FU-LfNPs exhibits high encapsulation efficiency (64±2.3%) and increased storage stability at 4°C. Competitive ligand binding and lysosomal colocalization studies suggested a receptor mediated uptake for LfNPs internalization in B16F10 cells. Moreover, 5-FU-LfNPs show a pH dependent drug release similar to endosomal pH (pH 5 and 6). In addition compared to free 5-FU, 5-FU- LfNPs showed a higher intracellular uptake, prolonged retention and improved cytotoxicity (2.7-fold) in melanoma cells (B16F10). To conclude, LfNPs represent a superior nano-carrier for the targeted delivery of 5-FU in melanoma cells intended for the efficient treatment of melanoma though detailed in vivo investigations are warranted.
Collapse
|
8
|
Hekmat A, Attar H, Seyf Kordi AA, Iman M, Jaafari MR. New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles. Molecules 2016; 21:molecules21091265. [PMID: 27657038 PMCID: PMC6274371 DOI: 10.3390/molecules21091265] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2016] [Revised: 09/17/2016] [Accepted: 09/17/2016] [Indexed: 01/04/2023] Open
Abstract
Intravenous administration of Taxotere® (a commercial form of docetaxel, DTX) leads to many problems such as hypersensitivity, hemolysis, cutaneous allergy, and patient refusal due to its prolonged injection. The oral absorption of DTX is very low due to its hydrophobic nature. The purpose of this study was to prepare and carry out an in vitro evaluation of DTX-loaded nanomicelles for oral administration in order to increase the oral delivery of DTX. Studied formulations were prepared with the two surfactants Tween 20 and Tween 80 and were characterized for their particle size, zeta potential, stability, encapsulation efficiency, stability studies in gastric fluid and intestinal fluid, toxicity studies in C26 colon carcinoma cell line, and cellular uptake. The prepared nanomicelles with particle size of around 14 nm and encapsulation efficiency of 99% were stable in gastric fluid and intestinal fluid for at least 6 h and IC50 decreased significantly after 72 h exposure compared to that of Taxotere®. Nanomicelles increased the water solubility of DTX more than 1500 times (10 mg/mL in nanomicelles compared to 6 µg/mL in water). Results of this study reveal that the new formulation of DTX could be used for the oral delivery of DTX and merits further investigation.
Collapse
Affiliation(s)
- Atefeh Hekmat
- Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
| | - Hossein Attar
- Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
| | - Ali Akbar Seyf Kordi
- Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
| | - Maryam Iman
- Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran 193955487, Iran.
| | - Mahmoud Reza Jaafari
- Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 917751365, Iran.
| |
Collapse
|
9
|
Wang H, Wu Y, Liu G, Du Z, Cheng X. A Biodegradable and Amphiphilic Linear-Dendritic Copolymer as a Drug Carrier Platform for Intracellular Drug Delivery. MACROMOL CHEM PHYS 2016. [DOI: 10.1002/macp.201600269] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Haibo Wang
- Textile Institute; College of Light Industry; Textile and Food Engineering; Sichuan University; Chengdu 610065 China
| | - Yan Wu
- Textile Institute; College of Light Industry; Textile and Food Engineering; Sichuan University; Chengdu 610065 China
| | - Gongyan Liu
- Key Laboratory of Leather Chemistry and Engineering of Ministry of Education; Sichuan University; Chengdu 610065 China
| | - Zongliang Du
- Textile Institute; College of Light Industry; Textile and Food Engineering; Sichuan University; Chengdu 610065 China
| | - Xu Cheng
- Textile Institute; College of Light Industry; Textile and Food Engineering; Sichuan University; Chengdu 610065 China
| |
Collapse
|
10
|
Han R, Sun Y, Kang C, Sun H, Wei W. Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy. J Drug Target 2016; 25:140-148. [PMID: 27356094 DOI: 10.1080/1061186x.2016.1207649] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Combination cancer therapy has attracted considerable attention due to its enhanced antitumor efficacy and reduced toxicity granted by synergistic effects over monotherapy. The application of nanotechnology is expected to achieve coencapsulation of multiple anticancer agents with enhanced therapeutic efficacy. Herein, a unique nanomicelle based on amphiphilic dendrimer (AmD) consisting of a hydrophilic polyamidoamine dendritic shell and a hydrophobic polylactide core is developed for effectively loading and shuttling 5-fluorouracil (5-Fu) and doxorubicin (Dox). The yielded drug-encapsulated dendritic nanomicelle (5-Fu/Dox-DNM) has a modest average size of 68.6 ± 3.3 nm and shows pH-sensitive drug release manner. The parallel activity of 5-Fu and Dox show synergistic anticancer efficacy. The IC50 value of 5-Fu/Dox-DNM toward human breast cancer (MDA-MB-231) cells was 0.25 μg/mL, presenting an 11.2-fold and 6.1-fold increase in cytotoxicity compared to Dox-DNM and 5-Fu-DNM, respectively. Furthermore, 5-Fu/Dox-DNM significantly inhibits the progression of tumor growth in the MDA-MB-231 xenograft tumor mice model. In conclusion, we have demonstrated that our AmD-based combination therapeutic system has promising potential to open an avenue for coencapsulation of multiple chemotherapeutic agents to promote superior anticancer effect.
Collapse
Affiliation(s)
- Rui Han
- a Department of Pharmacy , The First People's Hospital of Changzhou , Changzhou , China
| | - Yuan Sun
- b Department of Chemistry and Biochemistry , The Ohio State University , Columbus, OH , USA
| | - Chen Kang
- c Division of Pharmacology, College of Pharmacy , The Ohio State University , Columbus, OH , USA
| | - Huijing Sun
- d Nanjing Haiguang Applied Chemistry Research Institute, Aosaikang Pharmaceutical Co., Ltd , Nanjing , China
| | - Wenguang Wei
- e Department of Acupuncture , The First People's Hospital of Changzhou , Changzhou , China
| |
Collapse
|
11
|
Fan X, Zhao Y, Xu W, Li L. Linear-dendritic block copolymer for drug and gene delivery. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2016; 62:943-59. [PMID: 26952501 DOI: 10.1016/j.msec.2016.01.044] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2015] [Revised: 12/31/2015] [Accepted: 01/19/2016] [Indexed: 11/19/2022]
Abstract
Dendrimers as a new class of polymeric materials have a highly ordered branched structure, exact molecular weight, multivalency and available internal cavities, which make them extensively used in biology and drug-delivery. Concurrent with the development of dendrimers, much more attention is drawn to a novel block copolymer which combines linear chains with dendritic macromolecules, the linear-dendritic block copolymer (LDBC). Because of the different solubility of the contrasting regions, the amphiphilic LDBCs could self-assemble to form aggregates with special core-shell structures which exhibit excellent properties different from traditional micelles, such as lower critical micelle concentration, prolonged circulation in the bloodstream, better biocompatibility, and lower toxicity. The present review briefly describes the type of LDBC, the self-assembly behavior in solution, and the application in delivery system including the application as drug carriers and gene vectors. The interactions between block copolymers and drugs are also summarized to better understand the release mechanism of drugs from the linear-dendritic block copolymers.
Collapse
Affiliation(s)
- Xiaohui Fan
- Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan, Shandong Province 250012, China
| | - Yanli Zhao
- Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan, Shandong Province 250012, China
| | - Wei Xu
- Department of Pharmacy, Shandong Provincial Qian Foshan Hospital, Jinan, Shandong Province, China
| | - Lingbing Li
- Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan, Shandong Province 250012, China.
| |
Collapse
|
12
|
Bugno J, Hsu HJ, Hong S. Recent advances in targeted drug delivery approaches using dendritic polymers. Biomater Sci 2015; 3:1025-34. [PMID: 26221937 PMCID: PMC4519693 DOI: 10.1039/c4bm00351a] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Since they were first synthesized over 30 years ago, dendrimers have seen rapid translation into various biomedical applications. A number of reports have not only demonstrated their clinical utility, but also revealed novel design approaches and strategies based on the elucidation of underlying mechanisms governing their biological interactions. This review focuses on presenting the latest advances in dendrimer design, discussing the current mechanistic understandings, and highlighting recent developments and targeted approaches using dendrimers in drug/gene delivery.
Collapse
Affiliation(s)
- Jason Bugno
- Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.
| | | | | |
Collapse
|
13
|
Mohammadifar E, Nemati Kharat A, Adeli M. Polyamidoamine and polyglycerol; their linear, dendritic and linear–dendritic architectures as anticancer drug delivery systems. J Mater Chem B 2015; 3:3896-3921. [DOI: 10.1039/c4tb02133a] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
This review covers the latest advances in the conjugation of chemotherapeutics such as doxorubicin, paclitaxel, methotrexate, fluorouracil and cisplatin to dendritic polymers, including polyamidoamine dendrimers, hyperbranched polyglycerols and their linear analogues, with a focus on their cytotoxicity, biodistribution and biodegradability.
Collapse
Affiliation(s)
- Ehsan Mohammadifar
- School of Chemistry
- University College of Science
- University of Tehran
- Tehran
- Iran
| | - Ali Nemati Kharat
- School of Chemistry
- University College of Science
- University of Tehran
- Tehran
- Iran
| | - Mohsen Adeli
- Department of Chemistry
- Faculty of Science
- Lorestan University
- Khoramabad
- Iran
| |
Collapse
|
14
|
Gheybi H, Adeli M. Supramolecular anticancer drug delivery systems based on linear–dendritic copolymers. Polym Chem 2015. [DOI: 10.1039/c4py01437e] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The combination of two generations of polymers as linear–dendritic copolymers leads to hybrid systems with unique properties, which are of great interest for many applications. Herein, recent advances in anticancer drug delivery systems based on linear–dendritic copolymers have been reviewed.
Collapse
Affiliation(s)
- Homa Gheybi
- Department of Chemistry
- Faculty of Science
- Lorestan University
- Khorramabad
- Iran
| | - Mohsen Adeli
- Department of Chemistry
- Faculty of Science
- Lorestan University
- Khorramabad
- Iran
| |
Collapse
|
15
|
Whitton G, Gillies ER. Functional aqueous assemblies of linear-dendron hybrids. ACTA ACUST UNITED AC 2014. [DOI: 10.1002/pola.27316] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- Greg Whitton
- Department of Chemistry; The University of Western Ontario; 1151 Richmond Street London Ontario Canada N6A 5B7
| | - Elizabeth R. Gillies
- Department of Chemistry; The University of Western Ontario; 1151 Richmond Street London Ontario Canada N6A 5B7
- Department of Chemical and Biochemical Engineering; The University of Western Ontario; 1151 Richmond Street London Ontario Canada N6A 5B9
| |
Collapse
|